News in the Life Sciences Industry

MALMÖ, Sweden, April 17, 2019 /PRNewswire/ -- Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, summons to Annual General Meeting on Wednesday 22 Maj 2019 at 17.00 CEST at the auditorium next to the company's premises, Scheelevägen 22, Lund, Sweden. Registration... Read more ››

LUND, Sweden, April 17, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the Nomination Committee in Alligator Bioscience has presented its proposal for the annual shareholders' meeting on May 9, 2019, regarding election and remuneration of the... Read more ››

STOCKHOLM, April 17, 2019 /PRNewswire/ -- Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) - The Nomination Committee of Biotage has been informed that Reinhardt Vogt, who has been nominated to be elected as a Biotage Board member at the 24 April 2019 AGM, no longer is available for the... Read more ››

HUDDINGE, Sweden, April 16, 2019 /PRNewswire/ -- The shareholders of Karo Pharma Aktiebolag, reg. no. 556309-3359, are given notice of the annual general meeting to be held at 14:00 CET on 16 May 2019, at Näringslivets Hus, Storgatan 19 in Stockholm.

STOCKHOLM, April 16, 2019 /PRNewswire/ -- Moberg Pharma´s Annual Report for 2018 has been published and is available on www.mobergpharma.com

STOCKHOLM, April 16, 2019 /PRNewswire/ -- The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Tuesday, May 21, 2019, at 6:00 p.m., at the company's offices at Sveavägen 44, 7th floor, Stockholm,... Read more ››

STOCKHOLM, April 16, 2019 /PRNewswire/ -- The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, ("Oncopeptides" or the "Company") are hereby given notice to attend the Annual General Meeting to be held at Tändstickspalatset,... Read more ››

BOSTON and STOCKHOLM, April 16, 2019 /PRNewswire/ -- Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast... Read more ››

SINGAPORE, April 15, 2019 /PRNewswire/ -- Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors, today announced that it has entered into an agreement with Merck (known as MSD outside the US and... Read more ››

SINGAPORE, April 16, 2019 /PRNewswire/ -- Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors, today announced that it has entered into an agreement with MSD (tradename of Merck & Co., Inc.,... Read more ››

STOCKHOLM, April 15, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2018 is now available on the company's website, Read more ››

STOCKHOLM, April 15, 2019 /PRNewswire/ -- The sector fund Rhenman Healthcare Equity L/S was named a winner at this year's Nordic Hedge Awards; best-performing Nordic hedge fund for five years. The award was made in the category "Performance Award for 60 Months".

LUND, Sweden, April 15, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that its Annual Report for 2018 is now available on the company's website, Read more ››

LUND, Sweden, April 15, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that it has divested its entire equity stake in Genovis AB (NASDAQ Stockholm: GENO). The transaction... Read more ››

LINKÖPING, Sweden and ODENSE, Denmark, April 15, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

STOCKHOLM, April 15, 2019 /PRNewswire/ -- The shareholders in IRRAS AB (publ), reg. no. 556872-7134, are hereby invited to attend the annual general meeting ("AGM") to be held on Tuesday 14 May 2019 at 12.00 noon at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden.

SUNDSVALL, Sweden, April 15, 2019 /PRNewswire/ -- Permobil, a global leader in advanced rehabilitation technology, has updated its successful modular front wheel drive chair with new functions for improved body support and comfort, more flexible body positioning and smoother driving, as well... Read more ››